References
- Roukos DH . Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine . Drug Discov. Today22 ( 8 ), 1148 – 1164 ( 2017 ).
- Lawrence MS , StojanovP , MermelCHet al. Discovery and saturation analysis of cancer genes across 21 tumour types . Nature505 ( 7484 ), 495 – 501 ( 2014 ).
- Tirosh I , IzarB , PrakadanSMet al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq . Science352 ( 6282 ), 189 – 196 ( 2016 ).
- Roukos DH . Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapies . Drug Discov. Today21 ( 4 ), 663 – 673 ( 2016 ).
- Ziogas DE , KyrochristosID , RoukosDH . Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology . Drug Discov. Today23 ( 11 ), 1848 – 1872 ( 2018 ).
- Crick FH . On protein synthesis . Symp. Soc. Exp. Biol.12 , 138 – 163 ( 1958 ).
- Rask-Andersen M , AlmenMS , SchiothHB . Trends in the exploitation of novel drug targets . Nat. Rev. Drug Discov.10 ( 8 ), 579 – 590 ( 2011 ).
- US FDA ( 2018 ). https://www.fda.gov/ .
- National Comprehensive Cancer Network, Inc. ( 2018 ). https://www.nccn.org/
- Nair A , ChungHC , SunTet al. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer . Nat. Med.24 ( 4 ), 505 – 511 ( 2018 ).
- Zhong WZ , WangQ , MaoWMet al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, Phase III study . Lancet. Oncol.19 ( 1 ), 139 – 148 ( 2018 ).
- Pignon JP , TribodetH , ScagliottiGVet al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group . J. Clin. Oncol.26 ( 21 ), 3552 – 3559 ( 2008 ).
- Biankin AV , PiantadosiS , HollingsworthSJ . Patient-centric trials for therapeutic development in precision oncology . Nature526 ( 7573 ), 361 – 370 ( 2015 ).
- Yates LR , GerstungM , KnappskogSet al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing . Nat. Med.21 ( 7 ), 751 – 759 ( 2015 ).
- Mod EC , RoyS , ErnstJet al. Identification of functional elements and regulatory circuits by Drosophila modENCODE . Science330 ( 6012 ), 1787 – 1797 ( 2010 ).
- ENCODE Project Consortium . An integrated encyclopedia of DNA elements in the human genome . Nature489 ( 7414 ), 57 – 74 ( 2012 ).
- Turcot V , LuY , HighlandHMet al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity . Nat. Genet.50 ( 1 ), 26 – 41 ( 2018 ).
- Pang SY , TeoKC , HsuJSet al. The role of gene variants in the pathogenesis of neurodegenerative disorders as revealed by next generation sequencing studies: a review . Transl. Neurodegener.6 , 27 ( 2017 ).
- The Cancer Genome Atlas ( 2018 ). https://cancergenome.nih.gov/ .
- International Cancer Genome Consortium ( 2018 ). http://icgc.org/ .
- Fraser M , SabelnykovaVY , YamaguchiTNet al. Genomic hallmarks of localized, non-indolent prostate cancer . Nature541 ( 7637 ), 359 – 364 ( 2017 ).
- Bailey P , ChangDK , NonesKet al. Genomic analyses identify molecular subtypes of pancreatic cancer . Nature531 ( 7592 ), 47 – 52 ( 2016 ).
- Cancer Genome Atlas Research Network . Comprehensive and integrative genomic characterization of hepatocellular carcinoma . Cell169 ( 7 ), 1327 – 1341 ( 2017 ).
- Cancer Genome Atlas Network . Comprehensive molecular characterization of human colon and rectal cancer . Nature487 ( 7407 ), 330 – 337 ( 2012 ).
- Hayward NK , WilmottJS , WaddellNet al. Whole-genome landscapes of major melanoma subtypes . Nature545 ( 7653 ), 175 – 180 ( 2017 ).
- Waddell N , PajicM , PatchAMet al. Whole genomes redefine the mutational landscape of pancreatic cancer . Nature518 ( 7540 ), 495 – 501 ( 2015 ).
- Wang K , YuenST , XuJet al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer . Nat. Genet.46 ( 6 ), 573 – 582 ( 2014 ).
- Jamal-Hanjani M , WilsonGA , McGranahanNet al. Tracking the evolution of non-small-cell lung cancer . N. Eng. J. Med.376 ( 22 ), 2109 – 2121 ( 2017 ).
- Frenel JS , CarreiraS , GoodallJet al. Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration . Clin. Cancer Res.21 ( 20 ), 4586 – 4596 ( 2015 ).
- Olsson E , WinterC , GeorgeAet al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease . EMBO Mol. Med.7 ( 8 ), 1034 – 1047 ( 2015 ).
- Hyman DM , Piha-PaulSA , WonHet al. HER kinase inhibition in patients with HER2- and HER3-mutant cancers . Nature554 ( 7691 ), 189 – 194 ( 2018 ).
- Gunter C . Quantitative genetics . Nature456 ( 7223 ), 719 ( 2008 ).